Ocular Therapeutix Inc
Change company Symbol lookup
Select an option...
OCUL Ocular Therapeutix Inc
FCO Aberdeen Global Income Fund Inc.
DTEC ALPS Disruptive Technologies ETF
$RUIRETAILT Russell 1000 RGS Retail Total Return
BAC Bank of America Corp
MA Mastercard Inc
AAPL Apple Inc
AA Alcoa Corp
AMD Advanced Micro Devices Inc
PFE Pfizer Inc
Go

Health Care : Pharmaceuticals | Small Cap Growth
Company profile

Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the development, manufacturing and commercialization of therapies for diseases and conditions of the eye using its proprietary hydrogel platform technology. Its lead product candidate, DEXTENZA (dexamethasone insert) for intracanalicular use, has completed Phase III clinical development for the treatment of ocular pain and inflammation following ophthalmic surgery. OTX-TP (travoprost insert) is in Phase III clinical development for glaucoma and ocular hypertension. Its earlier stage assets include OTX-TIC, a sustained release travoprost intracameral injection for the treatment of moderate to severe glaucoma and ocular hypertension, as well as sustained release intravitreal injections for the treatment of retinal diseases. These injections include the development of OTX-TKI, a tyrosine kinase inhibitor, and, in collaboration with Regeneron an extended release protein-based anti-vascular endothelial growth factor trap.

Closing Price
$19.91
Day's Change
-0.17 (-0.85%)
Bid
--
Ask
--
B/A Size
--
Day's High
20.56
Day's Low
19.07
Volume
(Heavy Day)
Volume:
941,619

10-day average volume:
774,244
941,619
  • Prev Close
    20.08
  • Today's Open
    20.22
  • Day's Range
    19.07-20.56
  • Avg Vol (10-day)
    774.2K
  • Last (time)
    3:59p ET 01/20/21
  • Last (size)
    300
  • 52-Wk Range
    3.78 - 24.30
    LowHigh
  • (03/13/20 - 12/16/20)
    18.07%
  • 90.3%
  • Market Cap
    1.5B
  • Shares Outstanding
    75.3M
  • -1.77
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 2.1
  • 54.29
  • (% of float 12/31/20)
    8.12

Latest News

January 20, 2021
5:00 am ET
BusinessWire
January 07, 2021
5:00 am ET
BusinessWire
December 28, 2020
5:00 am ET
BusinessWire
December 22, 2020
5:45 am ET
BusinessWire
December 15, 2020
6:47 pm ET
BusinessWire
December 14, 2020
1:13 pm ET
BusinessWire
November 23, 2020
5:00 am ET
BusinessWire
November 11, 2020
6:00 am ET
BusinessWire
November 09, 2020
1:01 pm ET
BusinessWire
November 05, 2020
2:36 pm ET
Accesswire
1:01 pm ET
BusinessWire
November 04, 2020
5:00 am ET
BusinessWire
October 30, 2020
5:00 am ET
BusinessWire
October 23, 2020
7:00 am ET
BusinessWire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.